Your browser doesn't support javascript.
loading
[Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].
Hu, M M; Yuan, Q Q; Zhang, X S; Yang, S; Wang, X; Wang, L; Chen, J Q; Zhang, W C; Wang, X M; Ge, X L; Shen, W B; Xu, Y G; Hao, C L; Zhou, Z G; Qie, S; Lu, N; Pang, Q S; Zhao, Y D; Sun, X C; Li, G F; Li, L; Qiao, X Y; Liu, M L; Wang, Y D; Li, C; Zhu, S C; Han, C; Zhang, K X; Xiao, Z F.
Affiliation
  • Hu MM; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Yuan QQ; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Zhang XS; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Yang S; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Wang X; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang L; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Chen JQ; Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Zhang WC; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China.
  • Wang XM; Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China.
  • Ge XL; Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Shen WB; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Xu YG; Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology Beijing 100730, China.
  • Hao CL; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Zhou ZG; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Qie S; Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China.
  • Lu N; Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China.
  • Pang QS; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China.
  • Zhao YD; Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China.
  • Sun XC; Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Li GF; Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology Beijing 100730, China.
  • Li L; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Qiao XY; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Liu ML; Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China.
  • Wang YD; Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China.
  • Li C; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Zhu SC; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Han C; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Zhang KX; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.
  • Xiao ZF; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi ; 42(8): 676-681, 2020 Aug 23.
Article in Zh | MEDLINE | ID: mdl-32867461
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2020 Document type: Article Affiliation country: